{"id":2043,"date":"2018-09-15T11:03:21","date_gmt":"2018-09-15T11:03:21","guid":{"rendered":"http:\/\/lyl-biotic.com018\/09\/15\/saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten\/"},"modified":"2018-09-18T19:01:58","modified_gmt":"2018-09-18T19:01:58","slug":"saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten","status":"publish","type":"post","link":"https:\/\/lyl-biotic.com\/et\/saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten\/","title":{"rendered":"Saccharomyces boulardii reduce risk of diarrhea when travelling or beginning kindergarten"},"content":{"rendered":"<h6 class=\"short text_box\">Reisik\u00f5hulahtisust iseloomustab k\u00f5hulahtisus v\u00f5i -kinnisus, k\u00f5huvalu ja teised mao-sooletrakti h\u00e4ired, mida p\u00f5evad suurem osa inimesi, kui nad satuvad v\u00e4ljapoole oma tavap\u00e4rast keskkonda \u201ev\u00f5\u00f5raste bakterite\u201c piiramisr\u00f5ngasse. S\u00f5ltuvalt reisi sihtkohast kogevad reisik\u00f5hulahtisust 5% kuni 50% inimest.<\/h6>\n<div class=\"txt opn\">\n<div class=\"text_box\">\n<h6>12 topeltpimeda, platseebo-kontrollitud uuringu kokkuv\u00f5te t\u00f5endab, et probiootikumid on paljulubavad reisik\u00f5hulahtisuse prof\u00fclaktikas. Saccharomyces boulardii ja kahe probiootilise bakteri Lactobacillus acidophilus ja Bifidobacterium bifidum segu on m\u00e4rkimisv\u00e4\u00e4rselt t\u00f5husad. [1] S. Boulardii tarvitajate r\u00fchmas esines reisik\u00f5hulahtisust m\u00f5lemas uuringus keskmiselt 5%\u201311%. [2] [3]<\/h6>\n<h6>Kollaritsch et al on teostanud seni k\u00f5ige ulatuslikumaid uuringuid Saccharomyces boulardii soodsa m\u00f5ju kohta reisik\u00f5hulahtisuse puhul. Peamine j\u00e4reldus \u2013 probiootikumid on t\u00f5hus \u00a0vahend prof\u00fclaktikaks. Nende kasutamine umbes n\u00e4dal enne reisi v\u00f5ib v\u00e4hendada v\u00f5imalust haigestuda k\u00f5hulahtisusse. \u00dches uuringus j\u00e4lgiti 1231 Austria turisti, kes reisisid soojadesse maadesse. Nad tarvitasid 3 n\u00e4dalat m\u00f5nd S. boulardii annustest (250 v\u00f5i 500 mg) v\u00f5i platseebotablette. Reisijad alustasid probiootikumide kuuri 5 p\u00e4eva enne reisi ning j\u00e4tkasid kogu reisi ajal. Reisik\u00f5hulahtisust kogesid 43% platseebor\u00fchmast, seevastu oluliselt v\u00e4hem 250 mg (34%) ja 500 mg (32%) S. boulardii r\u00fchmas.[2]\u00a0 Teises Kollaritsch et al uuringus m\u00e4\u00e4rati 1016 austerlasel, kes suundusid P\u00f5hja-Aafrikasse, Kesk-Itta ja Kaug-Itta, 250 mg\/d (5 \u00d7 10<sup>9<\/sup>)\u00a0S. boulardii, 1000 mg\/d (2 \u00d7 10<sup>10<\/sup>)\u00a0S. boulardii\u00a0v\u00f5i platseebo, mida hakati tarvitama 5 p\u00e4eva enne reisi. S. boulardii v\u00e4hendas oluliselt k\u00f5hulahtisusse haigestunud turistide arvu.\u00a0 Reisik\u00f5hulahtisist koges 39% platseebor\u00fchmast, aga ainult 34% 250 mg S. Boulardiir\u00fchmast ja 29% 500 mg S. Boulardii r\u00fchmast (P\u00a0&lt; 0.05).[3]<\/h6>\n<\/div>\n<\/div>\n<ol>\n<li>McFarland LV. Meta-analysis of probiotics for the prevention of traveler&#8217;s diarrhea. Travel Med Infect Dis.\u00a02007 Mar;5(2):97-105. Epub 2005 Dec 5.<\/li>\n<li>Kollaritsch H, Kremsner P, Wiedermann , G , Scheiner O. Prevention of traveller\u2019s diarrhea: comparison of different non-antibiotic preparations.\u00a0Travel Med Internatl.\u00a01989;7:9\u201318.<\/li>\n<li>Kollaritsch H, Holst H, Grobara P, Wiedermann G. [Prevention of traveler&#8217;s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]\u00a0Fortschr Med.\u00a01993;111:152\u2013156<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Reisik\u00f5hulahtisust iseloomustab k\u00f5hulahtisus v\u00f5i -kinnisus, k\u00f5huvalu ja teised mao-sooletrakti h\u00e4ired, mida p\u00f5evad suurem osa inimesi, kui nad satuvad v\u00e4ljapoole oma tavap\u00e4rast keskkonda \u201ev\u00f5\u00f5raste bakterite\u201c piiramisr\u00f5ngasse. S\u00f5ltuvalt reisi sihtkohast kogevad reisik\u00f5hulahtisust 5% kuni 50% inimest. 12 topeltpimeda, platseebo-kontrollitud uuringu kokkuv\u00f5te t\u00f5endab, et probiootikumid on paljulubavad reisik\u00f5hulahtisuse prof\u00fclaktikas. Saccharomyces boulardii ja kahe probiootilise bakteri Lactobacillus acidophilus ja [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1889,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[43],"tags":[],"_links":{"self":[{"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/posts\/2043\/"}],"collection":[{"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/users\/1\/"}],"replies":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/comments\/?post=2043"}],"version-history":[{"count":2,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/posts\/2043\/revisions\/"}],"predecessor-version":[{"id":2045,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/posts\/2043\/revisions\/2045\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/media\/1889\/"}],"wp:attachment":[{"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/media\/?parent=2043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/categories\/?post=2043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lyl-biotic.com\/et\/wp-json\/wp\/v2\/tags\/?post=2043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}